YAP1 and central nervous system cancer: An extensive analysis of 9,125 tumor specimens unveiled a widespread dysregulation of the co-transcription factors YAP/TAZ across diverse cancer categories including medulloblastoma, glioma, neuroblastoma, colorectal, liver, lung, and pancreatic cancers (Sanchez-Vega et al., 2018).